Advancing Drug Discovery
with iPSC Solutions & Primary Cell Models

Offering iPSCs, primary cells, genome editing, and characterization, we deliver trusted solutions that drive discovery in drug development and disease modeling.

iPSCore — An all-in-one iPSC platform for generating predictive, human-relevant models that drive preclinical drug discovery forward. Learn More

High-Throughput iPSC — Scalable, high volume, iPSC screening platforms built for speed, consistency, and drug discovery demands. Learn More

iPS Cell Generation — Custom reprogramming of somatic cells into fully characterized iPSC lines using non-integrating methods. Learn More

Genome Editing — CRISPR-based editing in iPSCs for isogenic disease models and precision target validation. Learn More

iPSC Differentiation — Reproducible differentiation into neurons, cardiomyocytes, hepatocytes, and more. Learn More

Custom Cell Isolation — Cell isolation tailored to your tissue source, donor criteria, and application needs.
Learn More

A Collaborative Approach to Off-Target Chemotherapy Toxicity Using Organoids

iXCells has joined an international collaboration with Rosebud Biosciences and Kantify to assess off-target chemotherapeutic toxicity using patient-derived organoids. By combining iXCells’ expertise in cellular reprogramming with advanced 3D organoid platforms and AI-driven analysis, this initiative enables the development of personalized, multi-organ toxicity profiles—supporting safer, more precise oncology research.

Read the article here

Let us help accelerate your next breakthrough.

Backed by proven scientific leadership and integrated human model platforms, iXCells supports more informed translational decisions from discovery through development.

Cell Portfolio

An extensive catalog of human and animal primary cells from healthy and diseased tissues to complement our collection of iPSCs and their derivatives.

PRECLINICAL CRO SERVICES

We offer iPSC reprogramming, Cas9 genome editing, directed differentiation, custom cell isolation, in vitro bioassays, and ASO screening services. Our team of PhD scientists provides disease-relevant, patent-derived models that accelerate drug discovery and disease understanding.

APPLICATIONS

We specialize in complex assay development and execution for research support. Our expertise includes multi-cellular model building, 3D liver model signaling studies, and compound screening for iPSC-derived neurons and human immune cells.

DISCOVER
OUR CRO SERVICES

What Your Peers say about us